lorazepam

Generic: lorazepam

Labeler: directrx
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lorazepam
Generic Name lorazepam
Labeler directrx
Dosage Form TABLET
Routes
ORAL
Active Ingredients

lorazepam .5 mg/1

Manufacturer
DirectRx

Identifiers & Regulatory

Product NDC 72189-351
Product ID 72189-351_2c4c8caf-0897-acf6-e063-6294a90a14c3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203572
DEA Schedule civ
Listing Expiration 2026-12-31
Marketing Start 2022-04-29

Pharmacologic Class

Established (EPC)
benzodiazepine [epc]
Chemical Structure
benzodiazepines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72189351
Hyphenated Format 72189-351

Supplemental Identifiers

RxCUI
197900
UNII
O26FZP769L
NUI
N0000175694 M0002356

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lorazepam (source: ndc)
Generic Name lorazepam (source: ndc)
Application Number ANDA203572 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • .5 mg/1
source: ndc
Packaging
  • 2 TABLET in 1 BOTTLE (72189-351-02)
  • 30 TABLET in 1 BOTTLE (72189-351-30)
  • 60 TABLET in 1 BOTTLE (72189-351-60)
source: ndc

Packages (3)

72189-351-02 2 TABLET in 1 BOTTLE (72189-351-02) 72189-351-30 30 TABLET in 1 BOTTLE (72189-351-30) 72189-351-60 60 TABLET in 1 BOTTLE (72189-351-60)

Ingredients (1)

lorazepam (.5 mg/1)

Linked Drug Pages (1)

LORAZEPAM ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2c4c8caf-0897-acf6-e063-6294a90a14c3", "openfda": {"nui": ["N0000175694", "M0002356"], "unii": ["O26FZP769L"], "rxcui": ["197900"], "spl_set_id": ["ddcc0b2b-4be2-6d18-e053-2a95a90af987"], "pharm_class_cs": ["Benzodiazepines [CS]"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "manufacturer_name": ["DirectRx"]}, "finished": true, "packaging": [{"sample": false, "description": "2 TABLET in 1 BOTTLE (72189-351-02)", "package_ndc": "72189-351-02", "marketing_start_date": "20220429"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (72189-351-30)", "package_ndc": "72189-351-30", "marketing_start_date": "20220429"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (72189-351-60)", "package_ndc": "72189-351-60", "marketing_start_date": "20220429"}], "brand_name": "LORAZEPAM", "product_id": "72189-351_2c4c8caf-0897-acf6-e063-6294a90a14c3", "dosage_form": "TABLET", "pharm_class": ["Benzodiazepine [EPC]", "Benzodiazepines [CS]"], "product_ndc": "72189-351", "dea_schedule": "CIV", "generic_name": "LORAZEPAM", "labeler_name": "DirectRx", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LORAZEPAM", "active_ingredients": [{"name": "LORAZEPAM", "strength": ".5 mg/1"}], "application_number": "ANDA203572", "marketing_category": "ANDA", "marketing_start_date": "20220429", "listing_expiration_date": "20261231"}